PitchSend

Investor Presentaiton

4 MAX Healthcare Develop asset light adjacencies: Max Lab - Targeting to be amongst the top 5 players in the industry in next 5 years Organized diagnostics player to grow faster than overall diagnostic Industry driven by consolidation Indian diagnostic Industry market size (INR Bn) 472 FY17 684 FY20 950 FY23P Indian diagnostic Industry mix by type of providers 12-17% ■ Organized 35-40% Hospital based 45-50% Unorganized Shift to organized diagnostics centers driven by preference for higher quality and brands Max Lab (Non-captive Pathology SBU) - Over 13x revenue growth in 4 years Net revenue (INR Cr) +90% 41 24 13 5 66 17 35 EBITDA* (INR Cr) 18% 21% 9% 7% 7.4 4.5 1.6 1.0 -0.5 -5% Q1 Q2 Q3 Q4 Q1 FY21 FY21 FY21 FY21 FY22 FY17 FY18 FY19 FY20 FY21 Q4 Q1 EBITDA EBITDA margin (%) FY21 FY22 145+ Partner-run collection centres 9 Company owned collection centres 120+ Phlebotomist At Site (PAS) 165+ Pick-Up Points (PUPS) 17 Hospital based Lab Management (HLMs) 14 Cities of operations 1,900+ Tests in portfolio Note: All operating numbers as of June 30, 2021; Gross Merchandise Value (GMV) is total value paid by patient; Net Revenue represents GMV minus partner share; *margin computed on net revenue, based on 50:50 revenue share between Max Lab and hospitals for the samples tested in the network hospital labs 21

View entire presentation